John Wayne Cancer Institute (JWCI) is the eighth center in this multi-center trial testing the company’s percutaneous hepatic perfusion system for the isolated, high-dose delivery of the anticancer
PRX-08066 is a serotonin type 2B receptor (5-HT2B) antagonist that may represent a new mechanism of action for treating pulmonary hypertension (PH). This single-arm, open-label, Phase IIb study
Concentric Medical and InTouch Health said that they will work with hospitals to create centers of excellence for treating acute ischemic stroke, developing comprehensive programs that offer patients
John Kovach, president and CEO of Lixte, said: “Lixte has developed a series of novel compounds that inhibit the growth of common brain cancers of adults and children
Closing of the transaction is subject to receipt of certain regulatory approvals, as well as other customary conditions. If the necessary approvals are not obtained within one year,
Chronic allograft nephropathy, also known as chronic allograft dysfunction, is a fibrotic condition that is a cause of kidney transplant failure. STX-100 is a humanized monoclonal antibody licensed
This approval allows Evera Medical to assess the safety and effectiveness of the FulFil Lip implant in patients undergoing aesthetic lip enhancement. Enrollment into the study, named EIFFEL
The trial is being carried out by the Mayo phase two consortium under the National Cancer Institute’s (NCI’s) clinical trials agreement with Oncolytics, while Oncolytics will provide clinical
Under the terms of the merger agreement, the former American Tony shareholders exchanged their shares for Aim Smart shares so that, upon the closing of the merger, the
Remoxy, an investigational drug, is reported to be an abuse-resistant, controlled-release oxycodone for moderate-to-severe chronic pain. If approved, the companies believe Remoxy could be the first oxycodone on
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.